Sitagliptin Glenmark

Sitagliptin Glenmark is an oral medication used to help manage blood sugar levels in adults with type 2 diabetes. This EU-manufactured generic helps support healthy glucose metabolism when combined with diet and exercise. A reliable option for diabetes support with a well-established safety profile.

Sitagliptin belongs to a class of medications called DPP-4 inhibitors, which help regulate blood sugar by increasing insulin release after meals and reducing glucose production in the liver. It is commonly prescribed alongside diet and exercise to improve glycemic control in adults with type 2 diabetes. Many people use sitagliptin to maintain stable blood sugar levels throughout the day.

Sitagliptin works gradually to support the body’s natural ability to manage blood sugar after eating. Users often report feeling more balanced between meals, with fewer spikes in glucose levels. The effects are typically noticeable within a few weeks of consistent use, though individual responses may vary.

Store sitagliptin in a cool, dry place away from direct sunlight and out of reach of children. Keep the medication in its original packaging until ready to use. If you experience persistent nausea, dizziness, or signs of low blood sugar, contact a healthcare professional. Always inform your doctor about any other medications you are taking.

Sitagliptin may interact with certain medications, including strong CYP3A4 inhibitors, insulin, or sulfonylureas, which can affect blood sugar levels. Alcohol use may increase the risk of side effects such as dizziness or low blood sugar. Always review your full medication list with a healthcare provider before starting sitagliptin.